☆ 4.7 Letter

Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Get Full Text
Add to Collection

Journal

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 321, Issue 6, Pages 607-609

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jama.2018.20391

Keywords

-

Categories

Medicine, General & Internal

Funding

  1. Agency for Healthcare Research and Quality [R18HS024227]
  2. National Institute on Drug Abuse [UG1DA015815, UG3DA044831, 1R01DA044284, R01DA046468, 1R01DA045745, F30DA044700]
  3. US Centers for Disease Control and Prevention [U278601CE00, R01CE003008]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.